The use of Lopinavir and Ritonavir as a therapeutic alternative for COVID-19. Research, Society and Development, [S. l.], v. 10, n. 7, p. e43410716505, 2021. DOI: 10.33448/rsd-v10i7.16505. Disponível em: https://www.rsdjournal.org/rsd/article/view/16505. Acesso em: 5 dec. 2025.